Evidence map›Paper›PMID 41732518›Full record

ArticleNew microbes and new infections2026

A rare case of breakthrough tick-borne encephalitis in early adolescence after vaccination with four doses of TBE vaccine.

S Morgardt, M Veje, T Bergström, L Ivarsson, M Studahl

Abstract read
In one paragraph

Article in New microbes and new infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

S MorgardtDepartment of Infectious Diseases, NU Hospital Group, Trollhättan, Region Västra Götaland, Sweden.
M VejeDepartment of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
T BergströmDepartment of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
L IvarssonDepartment of Pediatric Radiology, Queen Silvias Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
M StudahlDepartment of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tick-borne encephalitis (TBE) is an emerging infectious disease with effective vaccines available. However, breakthrough TBE occurs in previously vaccinated patients, a condition that is difficult to diagnose. We report a case of a previously healthy teenager who fell severely ill and was hospitalized for three months despite full TBE vaccination. Initial fever and headache progressed during the first week to encephalitis and, since autoimmune encephalitis was suspected, treatment with immunoglobulins and methylprednisolone was given. This case demonstrates the delayed response of TBEV IgM, typical for breakthrough infection, and the diagnostic value of an early IgG response to the non-structural protein 1 (NS1) in the cerebrospinal fluid. It also discusses the diagnostic challenges, the phenomenon of serological cross reactions with other flaviviruses, and the potential effect of immunomodulatory treatment in TBE. Serial MRI examinations of the brain were performed and confirmed persistent changes years after onset. The reasons for the severe outcome are discussed, but remain unclear.

Indexed as

Breakthrough infectionCase reportCross-reactivityFlavivirusNeutralizing antibodiesNon-structural protein 1SerologyTick-borne encephalitisTick-borne encephalitis virusVaccination

Identifiers

PMID41732518
PMCPMC12924906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.